Long-Term pooled analysis of multicenter studies of cooled thermotherapy for benign prostatic hyperplasia: Results at three months through four years

Urology

Volumn 63, Issue 4, 2004, Pages 716-721

  Trock, Bruce J ^a   Brotzman, Michelle ^b   Utz, William J ^b   Ugarte, Roland R ^b   Kaplan, Steven A ^b   Larson, Thayne R ^b   Blute, Michael L ^b   Roehrborn, Claus G ^b   Partin, Alan W ^b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANADA; CONTROLLED STUDY; DATA ANALYSIS; HUMAN; HYPERTHERMIC THERAPY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; QUALITY OF LIFE; SYMPTOMATOLOGY; TREATMENT OUTCOME; UNITED KINGDOM; UNITED STATES; URINARY TRACT; URINE FLOW RATE;

AGED; BODY TEMPERATURE; CANADA; COLD; CROSS-CULTURAL COMPARISON; ENGLAND; HUMANS; MALE; MIDDLE AGED; MULTICENTER STUDIES; PROSTATIC HYPERPLASIA; QUALITY OF LIFE; SEVERITY OF ILLNESS INDEX; TRANSURETHRAL RESECTION OF PROSTATE; TREATMENT OUTCOME; UNITED STATES; URODYNAMICS; WATER;

EID: 1842789674     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.urology.2003.11.006     Document Type: Article

References (22)

1. Sarma A.V., Jacobsen S.J., Girman C.J., et al. Concomitant longitudinal changes in frequency of and bother from lower urinary tract symptoms in community dwelling men. J Urol. 168:2002;1446-1452.
2. Djavan B., Seitz C., Roehrborn C.G., et al. Targeted transurethral microwave thermotherapy versus alpha-blockade in benign prostatic hyperplasia outcomes at 18 months. Urology. 57:2001;66-70.
3. Thalmann G.N., Mattei A., Treuthardt C., et al. Transurethral microwave therapy in 200 patients with a minimum followup of 2 years urodynamic and clinical results. J Urol. 167:2002;2496-2501.
4. Kaplan S.A., Larson T.R., Utz W.J., et al. Combined long term outcomes stratified by patient age at treatment results of the Targis™ system multi-center study for benign prostatic hyperplasia. (abstract) J Urol. 167:(suppl):2002;295.
5. Miller P.D., Kastner C., Ramsey E.W., et al. Cooled thermotherapy for the treatment of benign prostatic hyperplasia durability of results obtained with the Targis System. Urology. 61:2003;1160-1164.
6. Roehrborn C.G., Blute M., Partin A., et al. Long term efficacy of a 28.5 minute cooled thermotherapy (TUMT) treatment compared with 60 minute treatment for benign prostatic hyperplasia. (abstract) J Urol. 167:(suppl):2002;291.
7. Larson T.R., Blute M.L., Bruskewitz R.C., et al. A high-efficiency microwave thermoablation system for the treatment of benign prostatic hyperplasia results of a randomized, sham-controlled, prospective, double-blind, multicenter clinical trial. Urology. 51:1998;731-742.
8. Blute M.L., Larson T. Minimally invasive therapies for benign prostatic hyperplasia. Urology. 58:(suppl 6A):2001;33-41.
9. Mebust W.K., Donovan J., Bosch R., et al. Symptoms evaluation, quality of life and sexuality. Cockert A.T.K., Khoury S., Aso Y., et al. Proceedings of the Third International Consultation on BPH. 1996;257-262 Scientific Communication International, Monaco.
10. DerSimonian R., Laird N. Meta-analysis in clinical trials. Control Clin Trials. 7:1986;177-188.
11. Roehrborn C.G., Boyle P., Bergner D., et al. PLESS Study Group. Serum prostate-specific antigen and prostate volume predict long-term changes in symptoms and flow rate results of a four-year, randomized trial comparing finasteride versus placebo. Urology. 54:1999;662-669.
12. Roehrborn C.G., Malice M., Cook T.J., et al. Clinical predictors of spontaneous acute urinary retention in men with LUTS and clinical BPH a comprehensive analysis of the pooled placebo groups of several large clinical trials. Urology. 58:2001;210-216.
13. Roehrborn C.G., McConnell J.D., Saltzman B., et al. PLESS (Proscar Long-term Efficacy and Safety Study) Group. Storage (irritative) and voiding (obstructive) symptoms as predictors of benign prostatic hyperplasia progression and related outcomes. Eur Urol. 42:2002;1-6.
14. Roehrborn C.G., McConnell J., Bonilla J., et al. Serum prostate specific antigen is a strong predictor of future prostate growth in men with benign prostatic hyperplasia PROSCAR long-term efficacy and safety study. J Urol. 163:2000;13-20.
15. Djavan B., Shariat S., Fakhari M., et al. Neoadjuvant and adjuvant alpha-blockade improves early results of high-energy transurethral microwave thermotherapy for lower urinary tract symptoms of benign prostatic hyperplasia a randomized, prospective clinical trial. Urology. 53:1999;251-259.
16. Wasson J.H., Reda D.J., Bruskewitz R.C., et al. Veterans Affairs Cooperative Study Group on Transurethral Resection of the Prostate. A comparison of transurethral surgery with watchful waiting for moderate symptoms of benign prostatic hyperplasia. N Engl J Med. 332:1995;75-79.
17. Nawrocki J.D., Bell T.J., Lawrence W.T., et al. A randomized controlled trial of transurethral microwave thermotherapy. Br J Urol. 79:1997;389-393.
18. Madersbacher S., Marberger M. Is transurethral resection of the prostate still justified? BJU Int. 83:1999;227-237.
19. Arai Y., Aoki Y., Okubo K., et al. Impact of interventional therapy for benign prostatic hyperplasia on quality of life and sexual function a prospective study. J Urol. 164:2000;1206-1211.
20. Larson T.R. Rationale and assessment of minimally invasive approaches to benign prostatic hyperplasia therapy. Urology. 59:(suppl 2A):2002;12-16.
21. Puppo P. Long-term effects on BPH of medical and instrumental therapies. Eur Urol. 39:(suppl 6):2001;2-6.
22. Blute M., Ackerman S.J., Rein A.L., et al. Cost effectiveness of microwave thermotherapy in patients with benign prostatic hyperplasia part II - results. Urology. 56:2000;981-987.